Elsayed, A.M.; Bayraktar, E.; Amero, P.; Salama, S.A.; Abdelaziz, A.H.; Ismail, R.S.; Zhang, X.; Ivan, C.; Sood, A.K.; Lopez-Berestein, G.;
et al. PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway. Int. J. Mol. Sci. 2021, 22, 1882.
https://doi.org/10.3390/ijms22041882
AMA Style
Elsayed AM, Bayraktar E, Amero P, Salama SA, Abdelaziz AH, Ismail RS, Zhang X, Ivan C, Sood AK, Lopez-Berestein G,
et al. PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway. International Journal of Molecular Sciences. 2021; 22(4):1882.
https://doi.org/10.3390/ijms22041882
Chicago/Turabian Style
Elsayed, Abdelrahman M., Emine Bayraktar, Paola Amero, Salama A. Salama, Abdelaziz H. Abdelaziz, Raed S. Ismail, Xinna Zhang, Cristina Ivan, Anil K. Sood, Gabriel Lopez-Berestein,
and et al. 2021. "PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway" International Journal of Molecular Sciences 22, no. 4: 1882.
https://doi.org/10.3390/ijms22041882
APA Style
Elsayed, A. M., Bayraktar, E., Amero, P., Salama, S. A., Abdelaziz, A. H., Ismail, R. S., Zhang, X., Ivan, C., Sood, A. K., Lopez-Berestein, G., & Rodriguez-Aguayo, C.
(2021). PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway. International Journal of Molecular Sciences, 22(4), 1882.
https://doi.org/10.3390/ijms22041882